Celadon Pharmaceuticals Plc (AIM:CEL)
London
· Delayed Price · Currency is GBP · Price in GBX 6.50
0.00 (0.00%)
Apr 25, 2025, 1:49 PM GMT+1
Celadon Pharmaceuticals Revenue
Celadon Pharmaceuticals had revenue of 63.00K GBP in the half year ending June 30, 2024, with 472.73% growth. This brings the company's revenue in the last twelve months to 130.00K, up 519.05% year-over-year. In the year 2023, Celadon Pharmaceuticals had annual revenue of 75.00K with 212.50% growth.
Revenue (ttm)
130.00K
Revenue Growth
+519.05%
P/S Ratio
34.42
Revenue / Employee
4.81K
Employees
27
Market Cap
4.47M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Celadon Pharmaceuticals News
- 18 days ago - AIM Market Roundup: Rome Resources, Celadon Pharmaceuticals, Churchill China - The Armchair Trader
- 19 days ago - AIM Market Roundup: Minoan Group, Invinity Energy, Thor Exploration - The Armchair Trader
- 20 days ago - AIM Market Roundup: Celadon Pharma, Oracle Power, Volex - The Armchair Trader
- 25 days ago - AIM Market Roundup: Celadon Pharma, Oracle Power, Zinnwald Lithium - The Armchair Trader
- 26 days ago - AIM Market Roundup: Distil, Strip Tinning, Quadrise - The Armchair Trader
- 27 days ago - AIM Market Roundup: Distil, Orchard Funding, Mirriad Ads - The Armchair Trader
- 4 weeks ago - AIM Market Roundup:Premier African Minerals, UK Oil & Gas, Naked Wines - The Armchair Trader
- 2 months ago - AIM Market Roundup: Trellus Health, Celadon Pharma, Nahl - The Armchair Trader